Robert Harrington to Atherosclerosis
This is a "connection" page, showing publications Robert Harrington has written about Atherosclerosis.
Connection Strength
1.098
-
Canakinumab for Atherosclerotic Disease. N Engl J Med. 2018 01 11; 378(2):199-200.
Score: 0.503
-
Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis. Clin Cardiol. 2014 Jun; 37(6):337-42.
Score: 0.384
-
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. Circulation. 2022 Aug 30; 146(9):657-672.
Score: 0.171
-
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 05 27; 384(21):1981-1990.
Score: 0.040